Related Experiment Video
Updated: Aug 26, 2025
12:45
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
5.8K
Retroperitoneal Sarcomas: a Current Review on Management.
Shraddha Patkar1, Abhay K Kattepur2, Nehal Khanna3
1Department of Gastrointestinal Oncology, Hepatobiliary Services, Tata Memorial Centre and HBNI, Dr Ernst Borges Marg, Parel, Mumbai 400012 India.
Indian Journal of Surgical Oncology
|October 3, 2022
Summary
Retroperitoneal sarcomas are complex tumors. Management involves surgery, radiation, chemotherapy, and targeted therapies to improve outcomes and local control.
Area of Science:
- Surgical Oncology
- Medical Oncology
- Radiation Oncology
Background:
- Retroperitoneal sarcomas are diverse tumors with unpredictable behavior.
- Prognosis hinges on tumor type, grade, and complete surgical removal.
- Achieving negative margins is crucial for patient outcomes.
Purpose of the Study:
- To provide an updated review of retroperitoneal sarcoma management.
- To highlight key treatment strategies and landmark clinical trials.
- To discuss the integration of novel therapeutic approaches.
Main Methods:
- Comprehensive literature review of retroperitoneal sarcoma management.
- Analysis of surgical techniques, including compartment and organ resection.
- Evaluation of neoadjuvant and adjuvant therapies (radiotherapy, chemotherapy).
Main Results:
- Surgical resection with negative margins is paramount.
- Multimodality treatment (surgery, radiation, chemotherapy) improves local control.
- Targeted therapies offer new avenues based on molecular targets.
Conclusions:
- Effective retroperitoneal sarcoma management requires a multidisciplinary approach.
- Advances in targeted therapies are transforming treatment paradigms.
- Continued research and clinical trials are essential for improving patient survival.
